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Abstract
A 42-year-old woman presented to our hospital owing to a history of right-sided proptosis of 4 
months duration, reporting no previous trauma, fever, or recent sinusitis. Her medical record 
included a diagnosis of Graves’ disease. The best corrected visual acuity (BCVA) was 20/20 and a 
30.2 visual field test was normal. A 3-Tesla magnetic resonance imaging (MRI) revealed an orbital 
apex meningioma approaching the walls of the sulcus chiasmaticus. A subsequent 60.4 perimetry 
test showed bilateral nasal visual field defects, thus confirming the involvement of the optic nerve. 
The reported case focuses on the differential diagnosis with Thyroid Eye Disease (TED) and the 
subsequent follow-up. 
Introduction
The most common cause of both bilateral and unilateral 
exophthalmos in the adult population is Thyroid Eye 
Disease (TED) [1]. The rate of ophthalmopathy cases among 
hyperthyroid patients reaches up to 90%, with a much lower 
value among hypothyroid patients ranging between 0.2 and 
8.6% [2]. 
Despite being usually associated with TED, unilateral 
exophthalmos has a broader inventory of diagnostic possibilities 
to be excluded compared to bilateral exophthalmos. The 
pathological conditions more extensively regarded in the 
differential diagnosis comprise: traumatic causes, congenital 
abnormalities, infectious diseases, granulomatous, inflammatory 
and vascular disorders, and orbital neoplasms [1].
We report the case of a 42-year-old woman with unilateral 
proptosis with particular stress on the difficulty entailed in 
formulating a correct differential diagnosis with TED and the 
importance of the valuable information added by proper use of 
diagnostic devices.
Case Presentation
A 42-year-old female presented to the hospital complaining 
of right-sided proptosis without pulsation or bruit which 
developed gradually over 4 months, reporting no history of 
trauma, fever, or recent sinusitis. The patient denied diplopia. 
Her past medical record was relevant for thyroid disease. In 
fact, Grave’s thyroiditis had been diagnosed 2 years before and 
propylthiouracil (PTU) 3 x 100 mg/day prescribed. The patient 
underwent visual acuity assessment, slit-lamp examination, 
intraocular pressure evaluation with Icare®, fundoscopy and 
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visual field testing (Humphrey 30.2 program) [3,4]. We used 
a Hertel exophthalmometer to assess the severity of proptosis. 
An eyelid activity score (EAS), where 0 = normal, 1 = upper lid 
margin just above the upper limbus (showing the ‘‘whites’’ of 
the eye), 2 = limbus to eyelid distance ≥1.5mm but <2mm and 
3 = limbus to eyelid distance ≥2mm, was estimated for each 
eye [5]. The Clinical Activity Score (CAS) and the NOSPECS 
score were used in the evaluation of disease activity and 
severity, respectively [6]. An endocrinological examination 
and thyroid function tests were required. We performed a 3T 
MRI (Discovery–MR750) to evaluate the extraocular muscles 
involvement. A visual field testing (Humphrey 60.4 program) 
was also completed for a thorough diagnostic evaluation.
On the first examination, the patient had a best corrected 
visual acuity (BCVA) of 20/20 in both eyes. The von Graefe’s 
sign was not detected and the EAS score was 0 in both eyes. She 
didn’t have lagophthalmos. The pupillary response, intraocular 
pressure, and fundus examination were normal. Values of Hertel 
exophthalmometry were 18 mm in the right eye and 16 mm in 
the left eye. The CAS score was 1 and the NOSPECS score was 1 as 
well. Thyroid function tests showed a good control of the disease.
The endocrinologist confirmed the diagnosis of Grave’s 
disease and the systemic treatment previously prescribed. The 
30.2 visual field test was normal (Figure 1a). We performed a 
3T MRI with Gadolinium-DTPA enhancement which unveiled a 
small soft tissue mass at the apex of the right orbit within the 
enhancing meningioma in the optic canal with growth along the 
walls of the sulcus chiasmaticus (Figure 2).
A diagnosis of unilateral proptosis associated with optic 
nerve meningioma was carried out. A 60.4 visual field test 
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showed bilateral nasal defects (Figure 1b). After two months, 
the patient’s BCVA was 20/20. An increase in the severity of 
proptosis with a value of 19 mm in the right eye was noted and 
the MRI showed an expanded lesion involving the ophthalmic 
vein (Figure 3).
A neurosurgical assessment ruled out either surgery or 
radiotherapy and a conservative approach with close supervision 
of any visual field and visual acuity deterioration was advised. The 
follow-up visits carried out every 6 months do not show significant 
modifications in the neuroradiological and ocular outcomes. 
Discussion
This case strongly upholds the importance of a thorough 
medical history in the evaluation of proptosis sometimes 
supported by appropriate instrumental investigations to 
formulate a definitive diagnosis. One should always keep 
in mind the likelihood of an orbital neoplasm as the cause of 
unilateral exophthalmos even in a patient carrying a diagnosis 
of thyroid disease older than 2 years. The evaluation through a 
60.4 visual field test could be a fast-diagnostic tool in cases of 
unilateral proptosis prior to performing an MRI. In fact, in our 
Figure 1. A) Humphrey automated visual field perimetry (30.2 program) was normal in both eyes. B)  Humphrey automated visual field perimetry (60.4 program ) 
showed a bilateral nasal defect.
Figure 2.  3T MRI A) Axial T1-weighted sequence showing a hyperintense mass with defined limits localized at the apex of the right orbit and partially in the optic 
foramen, highly suggestive of meningioma. B) Coronal T2-weighted sequence showing a hyperintense mass inside the orbit encasing the intraorbital portion of the 
optic nerve. C) Sagittal FIESTA sequence showing an iso-hypointense mass in the intraorbital portion of the optic nerve.
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case this test showed a defect in the visual field not associated 
with TED and it could plausibly aid in the differential diagnosis 
of controversial cases.
Optic nerve meningiomas are rare tumors of the anterior 
visual pathway [5] and the lesions can come into close contact 
with the optic nerve and its vascular supply. The surgical excision 
may be difficult and can result in postoperative blindness in the 
affected eye [7-11]. 
Radiotherapy has been shown to have good efficacy with 
local tumor control and has been recommended as the best 
option for most cases of progressive or advanced disease [9-12] 
but concerns regarding the safety of this treatment are still being 
discussed.
In conclusion, the preserved visual acuity of the patient 
described in our case report led to refrain from choosing the 
treatment described above, rather supporting more conservative 
measures while awaiting for an eventual deterioration of vision 
caused by any ensuing tumor expansion. 
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Figure 3. 3T MRI.  Axial T1 sequences before (A) and after G-DTPA administration (B) 
showing an isointense tumor that enhances intensely and homogeneously. The coronal T1-
weighted sequence shows a multilobulated tumor with positive enhancement located on the 
medial aspect of the right orbit close to the ipsilateral medial and inferior rectus muscle 
.The sagittal T1-weighted sequence shows a hypervascular tumor localized at the apex of 
the right orbit and around the intraorbital portion of the optic nerve.
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